Beyond Air, Inc.

NASDAQ:XAIR

0.42 (USD) • At close September 13, 2024
Bedrijfsnaam Beyond Air, Inc.
Symbool XAIR
Munteenheid USD
Prijs 0.419
Beurswaarde 19,468,829
Dividendpercentage 0%
52-weken bereik 0.356 - 3.15
Industrie Medical Devices
Sector Healthcare
CEO Mr. Steven Adam Lisi
Website https://www.beyondair.net

An error occurred while fetching data.

Over Beyond Air, Inc.

Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for

Vergelijkbare Aandelen

Fusion Pharmaceuticals Inc. logo

Fusion Pharmaceuticals Inc.

FUSN

21.55 USD

Rhythm Pharmaceuticals, Inc. logo

Rhythm Pharmaceuticals, Inc.

RYTM

49.62 USD

Profound Medical Corp. logo

Profound Medical Corp.

PROF

7.72 USD

Talkspace, Inc. logo

Talkspace, Inc.

TALK

1.96 USD

Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc.

ALDX

6.03 USD

Mainz Biomed B.V. logo

Mainz Biomed B.V.

MYNZ

0.305 USD

CymaBay Therapeutics, Inc. logo

CymaBay Therapeutics, Inc.

CBAY

32.48 USD

XBiotech Inc. logo

XBiotech Inc.

XBIT

7.06 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)